newsfilter
← Latest News
ACCESS Newswire·

Jaguar Health Research in Ethnobotanical Medicine Helps Advance Crofelemer Development for Genetically Defined Rare Congenital Gastrointestinal Disorders

Crofelemer delayed-release tablets are Jaguar's FDA-approved prescription drug under botanical guidance derived from the Croton lechleri tree. Crofelemer, in a novel liquid formulation, is being